Inositol hexaphosphate-loaded red blood cells prevent in vitro sickling

Transfusion

Volumn 50, Issue 10, 2010, Pages 2176-2184

  Bourgeaux, Vanessa ^a   Hequet, Olivier ^a   Campion, Yannick ^a   Delcambre, Gaëlle ^a   Chevrier, Anne Marie ^a   Rigal, Dominique ^a   Godfrin, Yann ^a,b  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b ERYTECH PHARMA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTIC ACID;

ADOLESCENT; ADULT; ARTICLE; DEOXYGENATION; DRUG EFFECT; DRUG MECHANISM; ERYTHROCYTE; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; REOXYGENATION; SICKLE CELL TRAIT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; ERYTHROCYTES; FEMALE; HUMANS; MALE; PHYTIC ACID; YOUNG ADULT;

EID: 78649487662     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2010.02663.x     Document Type: Article

References (27)

1. Girot R, Stankovic K, Lionnet F. New issues in adult sickle cell disease. Bull Acad Natl Med 2008;192:1395-409.
2. Wahl S, Quirolo KC. Current issues in blood transfusion for sickle cell disease. Curr Opin Pediatr 2009;21:15-21.
3. Vichinsky E. New therapies in sickle cell disease. Lancet 2002;360:629-31.
4. Swerdlow PS. Red cell exchange in sickle cell disease. Hematology Am Soc Hematol Educ Program 2006;48-53.
5. Koo AP. Transfusion in sickle cell anemia revisited. Transfusion 2009;49:821-3.
6. Stuart MJ, Nagel RL. Sickle-cell disease. Lancet 2004;364: 1343-60.
7. Gibson QH, Gray RD. The reaction of inositol hexaphosphate with hemoglobin. Biochem Biophys Res Commun 1970;41:415-20.
8. Bailleul C, Borrelly-Villereal MC, Chassaigne M, Ropars C. Modification of partial pressure of oxygen (P50) in mammalian red blood cells by incorporation of an allosteric effector of hemoglobin. Biotechnol Appl Biochem 1989;11: 31-40.
9. Isaacks RE, Harkness DR, Goldman PH, AdLer JL, Kim CY. Studies on avian erythrocyte metabolism. VII. Effect of inositol pentaphosphate and other organic phosphates on oxygen affinity of the embryonic and adult-type hemoglobins of the turkey embryo. Hemoglobin 1977;1:577-93.
10. Vincent SP, Lehn JM, Lazarte J, Nicolau C. Transport of the highly charged myo-inositol hexakisphosphate molecule across the red blood cell membrane: a phase transfer and biological study. Bioor Med Chem 2002;10:2825-34.
11. Franco RS, Weiner M, Wagner K, Martelo OJ. Incorporation of inositol hexaphosphate into red blood cells mediated by dimethyl sulfoxide. Life Sci 1983;32:2763-8.
12. Brüggemann U, Roux EC, Hannig J, Nicolau C. Lowoxygen- affinity red cells produced in a large-volume, continuous-flow electroporation system. Transfusion 1995; 35:478-86.
13. Mouneimne Y, Barhoumi R, Myers T, Slogoff S, Nicolau C. Stable rightward shifts of the oxyhemoglobin dissociation curve induced by encapsulation of inositol hexaphosphate in red blood cells using electroporation. FEBS Lett 1990; 275:117-20.
14. Kumpati J, Franco RS, Weiner M, Martelo OJ. Sickling as a function of oxygen delivery: effect of simulated transfusions of stored, fresh and inositol-hexaphosphate-loaded red cells. Blood Cells 1982;8:263-72.
15. Lagerberg JW, Truijens-de Lange R, de Korte D, Verhoeven AJ. Altered processing of thawed red cells to improve the in vitro quality during postthaw storage at 4°C. Transfusion 2007;47:2242-9.
16. Dost K, Tokul O. Determination of phytic acid in wheat and wheat products by reverse phase high performance liquid chromatography. Anal Chim Acta 2005;558:22-7.
17. Blakney GB, Dinwoodie AJ. A spectrophotometric scanning technique for the rapid determination of plasma hemoglobin. Clin Biochem 1975;8:96-102.
18. Wyse JW, Barker R, Franco RS, Martelo O, Butterfield DA. Electron spin resonance (ESR) studies of skeletal protein interactions in human erythrocyte membranes exposed to polyanions and in membranes prepared from inositol hexaphosphate (IHP)-incorporated low-affinity erythrocytes. Biochem Biophys Res Commun 1987;144:779-86.
19. Onyike AE, Ohene-Frempong K, Horiuchi K. Sickling in vitro at venous and arterial oxygen tensions of reticulocytes from patients with sickle cell disease. Biochem Biophys Res Commun 1995;211:504-10.
20. Osuagwu CG, Mbeyi CU. Altered plasma hexose sugar metabolism in sickle cell anaemia. Afr J Biochem Res 2007; 1:037-040.
21. Marangos PJ, Fox AW, Riedel BJ, Royston D, Dziewanowska ZE. Potential therapeutic applications of fructose-1,6- diphosphate. Expert Opin Investig Drugs 1998;7:615-23.
22. Tellone E, Ficarra S, Scatena R, Giardina B, Kotyk A, Russo A, Colucci D, Bellocco E, Lagana' G, Galtieri A. Influence of gemfibrozil on sulfate transport in human erythrocytes during the oxygenation-deoxygenation cycle. Physiol Res 2008;57:621-9.
23. Vichinsky EP. Current issues with blood transfusions in sickle cell disease. Semin Hematol 2001;38(1 Suppl 1):14-22.
24. Brown K, Subramony C, May W, Megason G, Liu H, Bishop P, Walker T, Nowicki MJ. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy. J Pediatr Hematol Oncol 2009;31:309-12.
25. Trudel M, Saadane N, Garel MC, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern JL, Rouyer-Fessard P, Vidaud D, Pachnis A, Roméo PH, Beuzard Y, Costantini F. Towards a transgenic mouse model of sickle cell. EMBO J 1991;10: 3157-65.
26. Trudel M, De Paepe ME, Chretien N, Saadane N, Jacmain J, Sorette M, Hoang T, Beuzard Y. Sickle cell disease of transgenic SAD mice. Blood 1994;84:3189-97.
27. Kaul DK, Liu XD, Chang HY, Nagel RL, Fabry ME. Effect of fetal hemoglobin on microvascular regulation in sickle transgenic-knockout mice. J Clin Invest 2004;114:1136-45.